Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario, Canada
David N. Fisman, Ashleigh R. Tuite
Canadian Medical Association Journal (2021) Vol. 193, Iss. 42, pp. E1619-E1625
Open Access | Times Cited: 349

Showing 1-25 of 349 citing articles:

Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
Tommy Nyberg, Neil M. Ferguson, Sophie Nash, et al.
The Lancet (2022) Vol. 399, Iss. 10332, pp. 1303-1312
Open Access | Times Cited: 1150
The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus
Ying Liu, Joacim Rocklöv
Journal of Travel Medicine (2021) Vol. 28, Iss. 7
Open Access | Times Cited: 556
Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant
Jun Zhang, Tianshu Xiao, Yongfei Cai, et al.
Science (2021) Vol. 374, Iss. 6573, pp. 1353-1360
Open Access | Times Cited: 289
Impact of the Delta variant on vaccine efficacy and response strategies
Lianlian Bian, Qiushuang Gao, Fan Gao, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 10, pp. 1201-1209
Open Access | Times Cited: 215
The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern
Lixin Lin, Ying Liu, Xiujuan Tang, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 213
COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis
Jonathon W. Senefeld, Massimo Franchini, Carlo Mengoli, et al.
JAMA Network Open (2023) Vol. 6, Iss. 1, pp. e2250647-e2250647
Open Access | Times Cited: 127
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 113
COVID-19: Challenges of Viral Variants
Jana L. Jacobs, Ghady Haidar, John W. Mellors
Annual Review of Medicine (2022) Vol. 74, Iss. 1, pp. 31-53
Open Access | Times Cited: 84
The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far
Vivek P. Chavda, Rajashri Bezbaruah, Kangkan Deka, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1926-1926
Open Access | Times Cited: 71
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 66
Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses
Alexandra Tauzin, Shang Yu Gong, Guillaume Beaudoin-Bussières, et al.
Cell Host & Microbe (2021) Vol. 30, Iss. 1, pp. 97-109.e5
Open Access | Times Cited: 97
Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance — COVID-NET, 14 States, January–August 2021
Christopher A. Taylor, Kadam Patel, Huong Pham, et al.
MMWR Morbidity and Mortality Weekly Report (2021) Vol. 70, Iss. 43, pp. 1513-1519
Open Access | Times Cited: 82
Quantitative SARS-CoV-2 Viral-Load Curves in Paired Saliva Samples and Nasal Swabs Inform Appropriate Respiratory Sampling Site and Analytical Test Sensitivity Required for Earliest Viral Detection
Emily S. Savela, Alexander Viloria Winnett, Anna E. Romano, et al.
Journal of Clinical Microbiology (2021) Vol. 60, Iss. 2
Open Access | Times Cited: 78
CoronaVac induces lower neutralising activity against variants of concern than natural infection
Vimvara Vacharathit, Pakorn Aiewsakun, Suwimon Manopwisedjaroen, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 10, pp. 1352-1354
Open Access | Times Cited: 76
Duration of Severe Acute Respiratory Syndrome Coronavirus 2 Natural Immunity and Protection Against the Delta Variant: A Retrospective Cohort Study
Priscilla Kim, Steven M. Gordon, Megan Sheehan, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e185-e190
Open Access | Times Cited: 64
Molecular evolution of SARS‐CoV‐2 from December 2019 to August 2022
Jonas Michel Wolf, Lucas Wolf, Graziele Lima Bello, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 54
SARS-CoV-2 infection in children and implications for vaccination
Jordan Nathanielsz, Zheng Quan Toh, Lien Anh Ha, et al.
Pediatric Research (2022) Vol. 93, Iss. 5, pp. 1177-1187
Open Access | Times Cited: 48
Impact of new variants on SARS-CoV-2 infectivity and neutralization: A molecular assessment of the alterations in the spike-host protein interactions
Mary Hongying Cheng, James Krieger, Anupam Banerjee, et al.
iScience (2022) Vol. 25, Iss. 3, pp. 103939-103939
Open Access | Times Cited: 45
Covid-19: virology, variants, and vaccines
Megan Young, Harry Crook, J. T. Scott, et al.
BMJ Medicine (2022) Vol. 1, Iss. 1, pp. e000040-e000040
Open Access | Times Cited: 43
Clinical characteristics of COVID-19 in hospitalized children during the Omicron variant predominant period
Kensuke Shoji, Takayuki Akiyama, Shinya Tsuzuki, et al.
Journal of Infection and Chemotherapy (2022) Vol. 28, Iss. 11, pp. 1531-1535
Open Access | Times Cited: 43
Emergence of SARS-CoV-2 Variants in the World: How Could This Happen?
Alfredo Parra-Lucares, Paula Segura, Verónica Rojas, et al.
Life (2022) Vol. 12, Iss. 2, pp. 194-194
Open Access | Times Cited: 42
SARS-CoV-2 VOC type and biological sex affect molnupiravir efficacy in severe COVID-19 dwarf hamster model
Carolin M. Lieber, Robert M. Cox, Julien Sourimant, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 42
Understanding the dynamic relation between wastewater SARS-CoV-2 signal and clinical metrics throughout the pandemic
Nada Hegazy, Aaron Cowan, Patrick M. D’Aoust, et al.
The Science of The Total Environment (2022) Vol. 853, pp. 158458-158458
Open Access | Times Cited: 41
Variability in COVID-19 symptom presentation during pregnancy and its impact on maternal and infant outcomes across the pandemic
Julia Günther, Yvonne Ziert, Kristin Andresen, et al.
International Journal of Infectious Diseases (2024) Vol. 146, pp. 107157-107157
Closed Access | Times Cited: 7
Rapid and accurate detection of SARS-CoV-2 mutations using a Cas12a-based sensing platform
Changsheng He, Cailing Lin, Guosheng Mo, et al.
Biosensors and Bioelectronics (2021) Vol. 198, pp. 113857-113857
Open Access | Times Cited: 41
Page 1 - Next Page

Scroll to top